GLP-1 Drugs Reduce Depression, Boost Stress-Calming Gut Bacteria
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"GLP-1 Drugs Reduce Depression, Boost Stress-Calming Gut Bacteria" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include BioWorld News, Courthouse News, Medical Xpress and Fierce Biotech. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 112d ago.
Quick answers
Why is "GLP-1 Drugs Reduce Depression, Boost Stress-Calming Gut Bacteria" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (5)
- Microbiota modulates the antidepressant effects of GLP-1 analogues BioWorld News · 136d ago
- Guts may hold the key to happiness Courthouse News · 136d ago
- GLP-1s may alleviate depression through the microbiome, mouse study suggests Medical Xpress · 136d ago
- GLP-1s may combat depression through a mood-boosting gut microbe Fierce Biotech · 136d ago
- GLP-1 Drugs Reduce Depression, Boost Stress-Calming Gut Bacteria Neuroscience News · 136d ago
Topics
Related trends
Triple-action weekly weight-loss drug reduces sleep apnea in two late-stage trials
A triple-action weekly weight-loss drug significantly reduces obstructive sleep apnea severity in two late-stage clinical trials.
Body clock link? New type of depression could affect millions
Coverage examines a newly identified form of depression potentially linked to the human body clock.
GLP-1 Side Effects vs. Benefits: Real Patient Experiences
Recent reporting examines the available evidence regarding weight-loss drugs and bone health.
Women On GLP-1s Are Revealing The Side Effects And Experiences No One Told Them About
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Your Sleep Habits May Point to a Specific Type of Depression, a New Study Finds
Recent scientific research reveals a newly identified type of depression tied directly to sleep habits and specific triggers.
Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.